References of the article: “A strong correlation exists between platelet consumption and platelet hyperactivation in COVID-19 patients. Pilot study of the patient cohort from CCH RAS Hospital (Troitsk).”
  1. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

    Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K. Leung, E. Lau, J. Wong, X. Xing, N. Xiang, Y. Wu, C. Li, Q. Chen, D. Li, T. Liu, J. Zhao, M. Liu, W. Tu, C. Chen, L. Jin, R. Yang, Q. Wang, S. Zhou, R. Wang, H. Liu, Y. Luo, Y. Liu, G. Shao, H. Li, Z. Tao, Y. Yang, Z. Deng, B. Liu, Z. Ma, Y. Zhang, G. Shi, T. Lam, J. Wu, G. Gao, B. Cowling, B. Yang, G. Leung, Z. Feng

    New England Journal of Medicine. 2020, 382, 1199-1207

  2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

    C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, B. Cao

    The Lancet. 2020, 395, 497-506

  3. Platelet gene expression and function in patients with COVID-19

    B. Manne, F. Denorme, E. Middleton, I. Portier, J. Rowley, C. Stubben, A. Petrey, N. Tolley, L. Guo, M. Cody, A. Weyrich, C. Yost, M. Rondina, R. Campbell

    Blood. 2020, 136, 1317-1329

  4. Thrombocytopenia and its association with mortality in patients with COVID‐19

    X. Yang, Q. Yang, Y. Wang, Y. Wu, J. Xu, Y. Yu, Y. Shang

    Journal of Thrombosis and Haemostasis. 2020, 18, 1469-1472

  5. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

    G. Lippi, M. Plebani, B. Henry

    Clinica Chimica Acta. 2020, 506, 145-148

  6. Platelets in COVID-19: “innocent by-standers” or active participants?

    O. An, A. Martyanov, M. Stepanyan, A. Boldova, S. Rumyantsev, M. Panteleev, F. Ataullakhanov, A. Rumyantsev, A. Sveshnikova

    Pediatric Hematology/Oncology and Immunopathology. , 20, 184-191

  7. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

    Q. Ye, B. Wang, J. Mao

    Journal of Infection. 2020, 80, 607-613

  8. Hematological findings and complications of COVID ‐19

    E. Terpos, I. Ntanasis‐Stathopoulos, I. Elalamy, E. Kastritis, T. Sergentanis, M. Politou, T. Psaltopoulou, G. Gerotziafas, M. Dimopoulos

    American Journal of Hematology. 2020, 95, 834-847

  9. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis

    M. Panigada, N. Bottino, P. Tagliabue, G. Grasselli, C. Novembrino, V. Chantarangkul, A. Pesenti, F. Peyvandi, A. Tripodi

    Journal of Thrombosis and Haemostasis. 2020, 18, 1738-1742

  10. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

    N. Tang, H. Bai, X. Chen, J. Gong, D. Li, Z. Sun

    Journal of Thrombosis and Haemostasis. 2020, 18, 1094-1099

  11. Incidence of thrombotic complications in critically ill ICU patients with COVID-19

    F. Klok, M. Kruip, N. van der Meer, M. Arbous, D. Gommers, K. Kant, F. Kaptein, J. van Paassen, M. Stals, M. Huisman, H. Endeman

    Thrombosis Research. 2020, 191, 145-147

  12. The trinity of COVID-19: immunity, inflammation and intervention

    M. Tay, C. Poh, L. Rénia, P. MacAry, L. Ng

    Nature Reviews Immunology. 2020, 20, 363-374

  13. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19

    R. Alon, M. Sportiello, S. Kozlovski, A. Kumar, E. Reilly, A. Zarbock, N. Garbi, D. Topham

    Nature Reviews Immunology. 2021, 21, 49-64

  14. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

    A. Bonaventura, A. Vecchié, L. Dagna, K. Martinod, D. Dixon, B. Van Tassell, F. Dentali, F. Montecucco, S. Massberg, M. Levi, A. Abbate

    Nature Reviews Immunology. 2021, 21, 319-329

  15. Tissue factor as a link between inflammation and coagulation

    M. Witkowski, U. Landmesser, U. Rauch

    Trends in Cardiovascular Medicine. 2016, 26, 297-303

  16. von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke

    F. Denorme, K. Vanhoorelbeke, S. De Meyer

    Frontiers in Immunology. , 10, 2884

  17. Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

    J. Hirsh, T. Warkentin, S. Shaughnessy, S. Anand, J. Halperin, R. Raschke, C. Granger, E. Ohman, J. Dalen

    Chest. 2001, 119, 64S-94S

  18. COVID-19 and its implications for thrombosis and anticoagulation

    J. Connors, J. Levy

    Blood. 2020, 135, 2033-2040

  19. Higher heparin dosages reduce thromboembolic complications in patients with COVID-19 pneumonia

    C. Carallo, F. Pugliese, E. Vettorato, C. Tripolino, L. Delle Donne, G. Guarrera, W. Spagnolli, S. Cozzio

    Journal of Investigative Medicine. 2021, 69, 884-887

  20. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis

    J. Gratz, M. Wiegele, M. Maleczek, H. Herkner, H. Schöchl, E. Chwala, P. Knöbl, E. Schaden

    Frontiers in Medicine. 2021, 8,

  21. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

    V. Bianconi, F. Violi, F. Fallarino, P. Pignatelli, A. Sahebkar, M. Pirro

    Drugs. 2020, 80, 1383-1396

  22. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling

    A. Sveshnikova, A. Balatskiy, A. Demianova, T. Shepelyuk, S. Shakhidzhanov, M. Balatskaya, A. Pichugin, F. Ataullakhanov, M. Panteleev

    Journal of Thrombosis and Haemostasis. 2016, 14, 2045-2057

  23. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting

    N. Podoplelova, A. Sveshnikova, Y. Kotova, A. Eckly, N. Receveur, D. Nechipurenko, S. Obydennyi, I. Kireev, C. Gachet, F. Ataullakhanov, P. Mangin, M. Panteleev

    Blood. 2016, 128, 1745-1755

  24. Flow cytometry for pediatric platelets

    A. Ignatova, E. Ponomarenko, D. Polokhov, E. Suntsova, P. Zharkov, D. Fedorova, E. Balashova, A. Rudneva, V. Ptushkin, E. Nikitin, A. Shcherbina, A. Maschan, G. Novichkova, M. Panteleev

    Platelets. 2019, 30, 428-437

  25. New Fundamentals in Hemostasis

    H. Versteeg, J. Heemskerk, M. Levi, P. Reitsma

    Physiological Reviews. 2013, 93, 327-358

  26. Clot Contraction Drives the Translocation of Procoagulant Platelets to Thrombus Surface

    D. Nechipurenko, N. Receveur, A. Yakimenko, T. Shepelyuk, A. Yakusheva, R. Kerimov, S. Obydennyy, A. Eckly, C. Léon, C. Gachet, E. Grishchuk, F. Ataullakhanov, P. Mangin, M. Panteleev

    Arteriosclerosis, Thrombosis, and Vascular Biology. 2019, 39, 37-47

  27. Platelet Apoptosis and Apoptotic Platelet Clearance by Macrophages in Secondary Dengue Virus Infections

    M. Alonzo, T. Lacuesta, E. Dimaano, T. Kurosu, L. Suarez, C. Mapua, Y. Akeda, R. Matias, D. Kuter, S. Nagata, F. Natividad, K. Oishi

    The Journal of Infectious Diseases. 2012, 205, 1321-1329

  28. The Impact of COVID-19 Disease on Platelets and Coagulation

    G. Wool, J. Miller

    Pathobiology. 2021, 88, 15-27

  29. Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

    Y. Zaid, F. Puhm, I. Allaeys, A. Naya, M. Oudghiri, L. Khalki, Y. Limami, N. Zaid, K. Sadki, R. Ben El Haj, W. Mahir, L. Belayachi, B. Belefquih, A. Benouda, A. Cheikh, M. Langlois, Y. Cherrah, L. Flamand, F. Guessous, E. Boilard

    Circulation Research. 2020, 127, 1404-1418

  30. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways

    J. Burkhart, M. Vaudel, S. Gambaryan, S. Radau, U. Walter, L. Martens, J. Geiger, A. Sickmann, R. Zahedi

    Blood. 2012, 120, e73-e82

  31. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

    S. Zhang, Y. Liu, X. Wang, L. Yang, H. Li, Y. Wang, M. Liu, X. Zhao, Y. Xie, Y. Yang, S. Zhang, Z. Fan, J. Dong, Z. Yuan, Z. Ding, Y. Zhang, L. Hu

    Journal of Hematology & Oncology. 2020, 13,

  32. Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia

    F. Taus, G. Salvagno, S. Canè, C. Fava, F. Mazzaferri, E. Carrara, V. Petrova, R. Barouni, F. Dima, A. Dalbeni, S. Romano, G. Poli, M. Benati, S. De Nitto, G. Mansueto, M. Iezzi, E. Tacconelli, G. Lippi, V. Bronte, P. Minuz

    Arteriosclerosis, Thrombosis, and Vascular Biology. 2020, 40, 2975-2989

  33. Cellular automata as models of complexity

    S. Wolfram

    Nature. 1984, 311, 419-424

  34. The biogenesis of platelets from megakaryocyte proplatelets

    S. Patel

    Journal of Clinical Investigation. 2005, 115, 3348-3354

  35. Thrombopoietin levels in patients with disorders of platelet production: Diagnostic potential and utility in predicting response to TPO Receptor agonists

    R. Makar, O. Zhukov, M. Sahud, D. Kuter

    American Journal of Hematology. 2013, 88, 1041-1044

  36. Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance

    K. Hoffmeister, H. Falet

    Thrombosis Research. 2016, 141, S68-S72

  37. Platelet reticulated forms, size indexes, and functional activity. Interactions in healthy volunteers

    V. V. Bodrova, O. N. Shustova, S. G. Khaspekova, and A. V. Mazurov

    Platelets. 2021, , 1-6

  38. Ultrastructural, transcriptional, and functional differences between human reticulated and non‐reticulated platelets

    L. Hille, M. Lenz, A. Vlachos, B. Grüning, L. Hein, F. Neumann, T. Nührenberg, D. Trenk

    Journal of Thrombosis and Haemostasis. 2020, 18, 2034-2046

  39. Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial

    S. Chakraborty, S. Alam, M. Sayem, M. Sanyal, T. Das, P. Saha, M. Sayem, B. Byapari, C. Tabassum, A. Kabir, M. Amin, A. Nabi

    EClinicalMedicine. 2020, 29-30, 100624

  40. Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders

    D. Schmoeller, M. Picarelli, T. Paz Munhoz, C. Poli de Figueiredo, H. Staub

    Frontiers in Medicine. 2017, 4,

  41. Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis

    S. Kovács, Z. Csiki, K. Zsóri, Z. Bereczky, A. Shemirani

    Platelets. 2019, 30, 139-147

  42. Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death

    W. Chen, J. Pan

    Biological Procedures Online. 2021, 23,

  43. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2

    S. Yin, M. Huang, D. Li, N. Tang

    Journal of Thrombosis and Thrombolysis. 2021, 51, 1107-1110

  44. The value of the platelet count and platelet indices in differentiation of COVID‐19 and influenza pneumonia

    N. Ozcelik, S. Ozyurt, B. Yilmaz Kara, A. Gumus, U. Sahin

    Journal of Medical Virology. 2021, 93, 2221-2226

  45. Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection

    R. Likic, D. Kuzmanic

    Wiener Klinische Wochenschrift. 2004, 116, 47-50

  46. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V

    A. Albanyan, M. Murphy, J. Rasmussen, C. Heegaard, P. Harrison

    Transfusion. 2009, 49, 99-107

  47. Procoagulant Platelets: Mechanisms of Generation and Action

    N. Podoplelova, D. Nechipurenko, A. Ignatova, A. Sveshnikova, M. Panteleev

    Hämostaseologie. 2021, 41, 146-153

  48. Collagen But Not Fibrinogen Surfaces Induce Bleb Formation, Exposure of Phosphatidylserine, and Procoagulant Activity of Adherent Platelets: Evidence for Regulation by Protein Tyrosine Kinase-Dependent Ca2+ Responses

    J. Heemskerk, W. Vuist, M. Feijge, C. Reutelingsperger, T. Lindhout

    Blood. 1997, 90, 2615-2625

  49. Coated-Platelets Improve Prediction of Stroke and Transient Ischemic Attack in Asymptomatic Internal Carotid Artery Stenosis

    A. Kirkpatrick, A. Tafur, A. Vincent, G. Dale, C. Prodan

    Stroke. 2014, 45, 2995-3001

  50. Inflammation, endothelium, and coagulation in sepsis

    M. Schouten, W. Wiersinga, M. Levi, T. van der Poll

    Journal of Leukocyte Biology. 2008, 83, 536-545

  51. The lung microvascular endothelium as a therapeutic target in severe influenza

    S. Armstrong, S. Mubareka, W. Lee

    Antiviral Research. 2013, 99, 113-118

  52. Thrombocytopenia and its association with mortality in patients with COVID‐19

    X. Yang, Q. Yang, Y. Wang, Y. Wu, J. Xu, Y. Yu, Y. Shang

    Journal of Thrombosis and Haemostasis. 2020, 18, 1469-1472

  53. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

    J. Thachil, N. Tang, S. Gando, A. Falanga, M. Cattaneo, M. Levi, C. Clark, T. Iba

    Journal of Thrombosis and Haemostasis. 2020, 18, 1023-1026

  54. Temporal Aspects of Heparin-Induced Thrombocytopenia

    T. Warkentin, J. Kelton

    New England Journal of Medicine. 2001, 344, 1286-1292

  55. Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

    T. Warkentin, M. Levine, J. Hirsh, P. Horsewood, R. Roberts, M. Gent, J. Kelton

    New England Journal of Medicine. 1995, 332, 1330-1336

  56. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

    C. S. Kow and S. S. Hasan

    Journal of Thrombosis and Thrombolysis. 2021, ,

  57. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

    J. Chan, Y. Yao, M. Yeung, W. Deng, L. Bao, L. Jia, F. Li, C. Xiao, H. Gao, P. Yu, J. Cai, H. Chu, J. Zhou, H. Chen, C. Qin, K. Yuen

    Journal of Infectious Diseases. 2015, 212, 1904-1913

  58. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

    I. Hung, K. Lung, E. Tso, R. Liu, T. Chung, M. Chu, Y. Ng, J. Lo, J. Chan, A. Tam, H. Shum, V. Chan, A. Wu, K. Sin, W. Leung, W. Law, D. Lung, S. Sin, P. Yeung, C. Yip, R. Zhang, A. Fung, E. Yan, K. Leung, J. Ip, A. Chu, W. Chan, A. Ng, R. Lee, K. Fung, A. Yeung, T. Wu, J. Chan, W. Yan, W. Chan, J. Chan, A. Lie, O. Tsang, V. Cheng, T. Que, C. Lau, K. Chan, K. To, K. Yuen

    The Lancet. 2020, 395, 1695-1704

  59. Small procoagulant platelets in diabetes type 2

    M. Edvardsson, M. Oweling, P. Järemo

    Thrombosis Research. 2020, 195, 1-7

  60. Coagulation testing and management in liver disease patients

    M. Stotts, J. Davis, N. Shah

    Current Opinion in Gastroenterology. 2020, 36, 169-176

  61. Platelet and coagulation disorders in newly diagnosed patients with pulmonary arterial hypertension

    E. Vrigkou, I. Tsangaris, S. Bonovas, P. Kopterides, E. Kyriakou, D. Konstantonis, A. Pappas, A. Anthi, A. Gialeraki, S. Orfanos, A. Armaganidis, A. Tsantes

    Platelets. 2019, 30, 646-651

  62. Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality

    N. Curry, A. Raja, J. Beavis, S. Stanworth, P. Harrison

    Journal of Extracellular Vesicles. 2014, 3, 25625